WASHINGTON D.C. (WOWO)- Federal regulators are taking a closer look at the booming wellness market. The U.S. Food and Drug Administration (FDA) has announced a formal review into seven widely used peptide compounds frequently touted on social media and by wellness influencers for weight loss, anti-aging, and tissue repair.

The review targets popular synthetic short-chain amino acid therapies that have gained massive traction online and through alternative health clinics. While proponents claim these compounds help with everything from rapid fat reduction and muscle recovery to longevity and cognitive enhancement, federal health officials are raising safety flags regarding unapproved manufacturing, a lack of extensive clinical data, and potential side effects.

Medical experts emphasize that many of these peptides are not approved for human consumption by the FDA, meaning consumers often purchase them through compounding pharmacies or online vendors with limited regulatory oversight.

“People are looking for quick fixes for weight loss or anti-aging, but bypassing standard regulatory channels introduces real health risks,” health analysts note. “The FDA’s decision to review these specific compounds highlights growing concern over safety and purity.”

The agency’s review is expected to determine whether stricter enforcement actions or distribution bans are necessary to protect consumers. Health professionals are urging individuals currently using peptide injections or supplements to consult their primary care physicians regarding potential risks